- Corporate Officers - S
- Sulat James R
Insider Trading History of Sulat James R
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sulat James R since 2005.
This trader's CIK number is 1229448.
At the time of last reporting, Sulat James R was the Officer of Mallinckrodt Plc. (stock ticker symbol MNK).
Also see all insider trading activities at Mallinckrodt Plc.
Note that in the past
SULAT JAMES R also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Memory Pharmaceuticals Corp (MEMY) by Sulat James R
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2006 | MEMY | 97,623 | $114,761 | 0 | $0 | 0 | $0 |
2005 | MEMY | 157,895 | $300,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Momenta Pharmaceuticals Inc (MNTA) by Sulat James R
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | MNTA | 0 | $0 | 0 | $0 | 14,356 | $88,500 |
2018 | MNTA | 0 | $0 | 0 | $0 | 19,234 | $199,665 |
2014 | MNTA | 0 | $0 | 0 | $0 | 5,000 | $44,250 |
2011 | MNTA | 0 | $0 | 0 | $0 | 10,000 | $128,650 |
Yearly summary of insider trading at Arch Therapeutics, Inc. (ARTH) by Sulat James R
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | ARTH | 0 | $0 | 0 | $0 | 30,000 | $11,100 |
2016 | ARTH | 111,111 | $0 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Mallinckrodt Plc (MNK) by Sulat James R
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | MNK | 30,000 | $254,474 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Maxygen Inc (MAXY) by Sulat James R
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2013 | MAXY | 0 | $0 | 0 | $0 | 57,162 | $0 |
Insider trading activities at 5 companies by Sulat James R:
1. Memory Pharmaceuticals Corp (MEMY)
2. Momenta Pharmaceuticals Inc (MNTA)
3. Arch Therapeutics, Inc. (ARTH)
4. Mallinckrodt Plc (MNK)
5. Maxygen Inc (MAXY)
Table 1. Insider trading of Memory Pharmaceuticals Corp (MEMY) by Sulat James R
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2006-10-16 | MEMY | Buy | 87,623 | 1.11 | 97,261 |
2006-06-05 | MEMY | Buy | 10,000 | 1.75 | 17,500 |
2005-09-23 | MEMY | Buy | 157,895 | 1.90 | 300,000 |
Table 2. Insider trading of Momenta Pharmaceuticals Inc (MNTA) by Sulat James R
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-06-20 | MNTA | Option Ex | 4,356 | .00 | 0 |
2019-05-24 | MNTA | Option Ex | 10,000 | 8.85 | 88,500 |
2018-09-06 | MNTA | Option Ex | 13,500 | 14.79 | 199,665 |
2018-06-20 | MNTA | Option Ex | 5,734 | .00 | 0 |
2014-10-17 | MNTA | Option Ex | 5,000 | 8.85 | 44,250 |
2011-12-19 | MNTA | Option Ex | 3,000 | 14.09 | 42,270 |
2011-02-14 | MNTA | Option Ex | 7,000 | 12.34 | 86,380 |
Table 3. Insider trading of Arch Therapeutics, Inc. (ARTH) by Sulat James R
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-07-16 | ARTH | Option Ex | 30,000 | .37 | 11,100 |
2016-05-26 | ARTH | Buy | 111,111 | .00 | 0 |
Table 4. Insider trading of Mallinckrodt Plc (MNK) by Sulat James R
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-03-14 | MNK | Buy | 15,000 | 8.42 | 126,314 |
2023-03-15 | MNK | Buy | 15,000 | 8.54 | 128,160 |
Table 5. Insider trading of Maxygen Inc (MAXY) by Sulat James R
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2013-06-30 | MAXY | Option Ex | 57,162 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Sulat James R
(Officer of Mallinckrodt Plc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.